BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16856439)

  • 61. Infant hearing screening: effects of timeline.
    Tsui PW; McPherson B; Wong EC; Ng IH
    Clin Otolaryngol; 2008 Apr; 33(2):108-12. PubMed ID: 18429859
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A multisite study to examine the efficacy of the otoacoustic emission/automated auditory brainstem response newborn hearing screening protocol: recommendations for policy, practice, and research.
    Gravel JS; White KR; Johnson JL; Widen JE; Vohr BR; James M; Kennalley T; Maxon AB; Spivak L; Sullivan-Mahoney M; Weirather Y; Meyer S
    Am J Audiol; 2005 Dec; 14(2):S217-28. PubMed ID: 16489865
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identifying congenital hearing impairment. Personal experience based on selective hearing screening.
    Molini E; Ricci G; Baroni S; Ciorba A; Bellocci A; Simoncelli C
    Acta Otorhinolaryngol Ital; 2004 Jun; 24(3):109-16. PubMed ID: 15584580
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of currently available devices designed for newborn hearing screening using automated auditory brainstem and/or otoacoustic emission measurements.
    Meier S; Narabayashi O; Probst R; Schmuziger N
    Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):927-34. PubMed ID: 15183584
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of hearing screening programs between one step with transient evoked otoacoustic emissions (TEOAE) and two steps with TEOAE and automated auditory brainstem response.
    Lin HC; Shu MT; Lee KS; Ho GM; Fu TY; Bruna S; Lin G
    Laryngoscope; 2005 Nov; 115(11):1957-62. PubMed ID: 16319605
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ligurian experience on neonatal hearing screening: clinical and epidemiological aspects.
    Calevo MG; Mezzano P; Zullino E; Padovani P; Serra G;
    Acta Paediatr; 2007 Nov; 96(11):1592-9. PubMed ID: 17937684
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Incidence of hypoacusia secondary to hyperbilirubinaemia in a universal neonatal auditory screening programme based on otoacoustic emissions and evoked auditory potentials].
    Núñez-Batalla F; Carro-Fernández P; Antuña-León ME; González-Trelles T
    Acta Otorrinolaringol Esp; 2008 Mar; 59(3):108-13. PubMed ID: 18364202
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The prevalence of congenital and early-onset hearing loss in Jordanian and Israeli infants.
    Attias J; Al-Masri M; Abukader L; Cohen G; Merlov P; Pratt H; Othman-Jebara R; Aber P; Raad F; Noyek A
    Int J Audiol; 2006 Sep; 45(9):528-36. PubMed ID: 17005496
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Initial audiologic assessment of infants referred from well baby, special care, and neonatal intensive care unit nurseries.
    Karzon RK; Lieu JE
    Am J Audiol; 2006 Jun; 15(1):14-24. PubMed ID: 16803788
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Otoacoustic emissions for newborn hearing screening].
    Liao H; Wu Z; Zhou T
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Feb; 34(1):21-4. PubMed ID: 12764789
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in transient-evoked otoacoustic emissions in the first month of life.
    Prieve BA; Hancur-Bucci CA; Preston JL
    Ear Hear; 2009 Jun; 30(3):330-9. PubMed ID: 19322090
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Universal newborn hearing screening in Mexico: results of the first 2 years.
    Yee-Arellano HM; Leal-Garza F; Pauli-Müller K
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1863-70. PubMed ID: 16914209
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Universal newborn hearing screening: feasibility in a community hospital.
    Huynh MT; Pollack RA; Cunningham RA
    J Fam Pract; 1996 May; 42(5):487-90. PubMed ID: 8642366
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hearing screening outcomes in infants of pregestational diabetic mothers.
    Stanton SG; Ryerson E; Moore SL; Sullivan-Mahoney M; Couch SC
    Am J Audiol; 2005 Jun; 14(1):86-93. PubMed ID: 16180972
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Screening of high-risk infants using distortion product otoacoustic emissions.
    Bowes M; Smith C; Tan AK; Varette-Cerre P
    J Otolaryngol; 1999 Aug; 28(4):181-4. PubMed ID: 10461253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effects of hypoxia, premature birth, infection, ototoxic drugs, circulatory system and congenital disease on neonatal hearing loss.
    Yoshikawa S; Ikeda K; Kudo T; Kobayashi T
    Auris Nasus Larynx; 2004 Dec; 31(4):361-8. PubMed ID: 15571908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Universal Newborn Hearing Screening introduced to NICU infants in Canterbury Province, New Zealand.
    Flynn M; Austin N; Flynn TS; Ford R; Buckland L
    N Z Med J; 2004 Nov; 117(1206):U1183. PubMed ID: 15570352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Neonatal hearing loss screening using otoacoustic emission with Echocheck].
    Torrico Román P; Trinidad Ramos G; de Cáceres Morillo MC; Lozano Sánchez S; López-Ríos Velasco J
    An Esp Pediatr; 2001 Mar; 54(3):283-9. PubMed ID: 11262258
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Universal newborn hearing screening in an inner-city, managed care environment.
    Isaacson G
    Laryngoscope; 2000 Jun; 110(6):881-94. PubMed ID: 10852501
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Neonatal hearing screening. A comparison of automatic auditory brainstem audiometry and otoacoustic emissions].
    Pedersen L; Møller TR; Wetke R; Ovesen T
    Ugeskr Laeger; 2008 Feb; 170(8):642-6. PubMed ID: 18364157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.